These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7480524)

  • 1. Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy.
    Segman RH; Shapira B; Gorfine M; Lerer B
    Psychopharmacology (Berl); 1995 Jun; 119(4):440-8. PubMed ID: 7480524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold.
    Shapira B; Lidsky D; Gorfine M; Lerer B
    J Clin Psychiatry; 1996 Jan; 57(1):32-8. PubMed ID: 8543545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the addition of pindolol accelerate the response to electroconvulsive therapy in patients with major depression? A double-blind, placebo-controlled pilot study.
    Shiah IS; Yatham LN; Srisurapanont M; Lam RW; Tam EM; Zis AP
    J Clin Psychopharmacol; 2000 Jun; 20(3):373-8. PubMed ID: 10831027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment failure with a tricyclic antidepressant followed by lithium addition and response to subsequent electroconvulsive therapy.
    Heijnen WT; van den Broek WW; Birkenhäger TK
    J Clin Psychiatry; 2008 Dec; 69(12):1887-91. PubMed ID: 19014754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of remission in 208 drug-resistant depressive patients treated with electroconvulsive therapy.
    Medda P; Mauri M; Toni C; Mariani MG; Rizzato S; Miniati M; De Simone L; Perugi G
    J ECT; 2014 Dec; 30(4):292-7. PubMed ID: 24625706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial.
    Brakemeier EL; Merkl A; Wilbertz G; Quante A; Regen F; Bührsch N; van Hall F; Kischkel E; Danker-Hopfe H; Anghelescu I; Heuser I; Kathmann N; Bajbouj M
    Biol Psychiatry; 2014 Aug; 76(3):194-202. PubMed ID: 24462229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.
    Nordenskjöld A; von Knorring L; Ljung T; Carlborg A; Brus O; Engström I
    J ECT; 2013 Jun; 29(2):86-92. PubMed ID: 23303421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of a three-phase treatment algorithm for inpatients with melancholic depression.
    Vermeiden M; Kamperman AM; Hoogendijk WJG; van den Broek WW; Birkenhäger TK
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):214-220. PubMed ID: 29505804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of antidepressant drugs during electroconvulsive therapy: a controlled study.
    Mayur PM; Gangadhar BN; Subbakrishna DK; Janakiramaiah N
    J Affect Disord; 2000 Apr; 58(1):37-41. PubMed ID: 10760556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant and cognitive effects of twice- versus three-times-weekly ECT.
    Lerer B; Shapira B; Calev A; Tubi N; Drexler H; Kindler S; Lidsky D; Schwartz JE
    Am J Psychiatry; 1995 Apr; 152(4):564-70. PubMed ID: 7694905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state.
    Medda P; Perugi G; Zanello S; Ciuffa M; Rizzato S; Cassano GB
    J ECT; 2010 Jun; 26(2):82-6. PubMed ID: 19710623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speed of response to bilateral ECT: an examination of possible predictors in two controlled trials.
    Shapira B; Lerer B
    J ECT; 1999 Sep; 15(3):202-6. PubMed ID: 10492858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
    Prudic J; Haskett RF; McCall WV; Isenberg K; Cooper T; Rosenquist PB; Mulsant BH; Sackeim HA
    J ECT; 2013 Mar; 29(1):3-12. PubMed ID: 23303417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression: a randomized, double-blind, controlled study.
    Spaans HP; Verwijk E; Comijs HC; Kok RM; Sienaert P; Bouckaert F; Fannes K; Vandepoel K; Scherder EJ; Stek ML; Kho KH
    J Clin Psychiatry; 2013 Nov; 74(11):e1029-36. PubMed ID: 24330903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and benefit in the choice of ECT schedule. Twice versus three times weekly ECT.
    Shapira B; Tubi N; Drexler H; Lidsky D; Calev A; Lerer B
    Br J Psychiatry; 1998 Jan; 172():44-8. PubMed ID: 9534831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy.
    Shapira B; Gorfine M; Lerer B
    Convuls Ther; 1995 Jun; 11(2):80-5. PubMed ID: 7552058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial.
    Yildiz A; Mantar A; Simsek S; Onur E; Gökmen N; Fidaner H
    J ECT; 2010 Jun; 26(2):104-10. PubMed ID: 19935091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
    McCall WV; Rosenquist PB; Kimball J; Haskett R; Isenberg K; Prudic J; Lasater B; Sackeim HA
    J ECT; 2011 Jun; 27(2):97-102. PubMed ID: 21206285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.